70 results
8-K
EX-10.1
SKYE
Skye Bioscience Inc
9 Jan 15
Entry into a Material Definitive Agreement
12:00am
in a union labor dispute or, to the knowledge of the Company or any of its Subsidiaries, is any such dispute threatened. None of the Company's or its … Subsidiaries' employees is a member of a union, neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement
8-K
EX-2.1
SKYE
Skye Bioscience Inc
21 Aug 23
Skye Completes $17M Financing and Acquires Novel Phase 2-Ready CB1-Inhibiting Monoclonal Antibody
8:36am
by, or has a duty to bargain under, any collective bargaining agreement or other Contract with a labor union or labor organization representing any of its … employees, and there is no labor union or labor organization representing or, to the Company’s Knowledge, purporting to represent or seeking to represent
8-K
EX-10.1
oqt zzb3bnig
29 Apr 20
Entry into a Material Definitive Agreement
4:37pm
8-K
EX-10.1
87zn6grac gc
12 Oct 18
Nemus Bioscience Announces that Emerald Health Sciences has Provided a Credit Facility of up to $20
6:03am
8-K
EX-10.1
8to0j7e24
21 Aug 23
Skye Completes $17M Financing and Acquires Novel Phase 2-Ready CB1-Inhibiting Monoclonal Antibody
8:36am
8-K
EX-10.1
8x61abuenzh9h3l
13 Mar 24
Entry into a Material Definitive Agreement
4:13pm
8-K
EX-10.1
zvq3j6
29 Jan 24
Skye Bioscience Announces $50.25 Million Private Placement Equity Financing
8:02am
8-K
EX-10.1
vzxr2of9 dg769
21 Nov 19
Emerald Bioscience Announces $2.0 Million Registered Direct Offering
5:21pm
424B3
t8jxmnfnsdhhe5eehzq
9 Aug 19
Prospectus supplement
4:57pm
424B3
4kojx9 thiwg3cz
10 May 19
Prospectus supplement
12:00am